| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |